Conflict of interest: A. Asgar is a Consultant for Gore Medical.
Valvular and Structural Heart Diseases
First experience with the new GORE® septal occluder for the closure of multiple atrial septal defects
Version of Record online: 27 FEB 2013
Copyright © 2012 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 81, Issue 7, pages 1238–1242, 1 June 2013
How to Cite
Freixa, X., Garceau, P. and Asgar, A. W. (2013), First experience with the new GORE® septal occluder for the closure of multiple atrial septal defects. Cathet. Cardiovasc. Intervent., 81: 1238–1242. doi: 10.1002/ccd.24508
- Issue online: 24 MAY 2013
- Version of Record online: 27 FEB 2013
- Accepted manuscript online: 28 MAY 2012 04:35AM EST
- Manuscript Accepted: 19 MAY 2012
- Manuscript Received: 21 DEC 2011
- atrial septal defect;
- GORE HELEX;
- multiple defects
Transcatheter closure of an atrial septal defect (ASD) is considered the standard of care for most of the patients with secundum ASD. The existence of multiple or fenestrated ASD may constitute a challenge to achieve a satisfactory result. Data on the usage of multiple devices for closing multiple defects are limited. The GORE® Septal Occluder (GSO) represents a new generation of transcatheter ASD occluders with a design that provides superior conformability, apposition, and closure performance compared with the previous GORE® HELEX device. The present case report describes the first clinical experience with the implantation of two GSO devices in a patient with multiple ASDs and fenestrated septum. © 2012 Wiley Periodicals, Inc.